The outcome of adults and children with Acute Promyelocytic Leukemia (APL) has dramatically
changed since the introduction of all trans retinoic acid (ATRA) therapy. Based on the …

To the Editor: This report assesses the impact of the COVID-19 pandemic on pediatric cancer
patients over an 8-week period elapsing from the day of the Italian outbreak (February 20, …

INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …

INTRODUCTION Clinical outcomes of human severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…

Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
contribute to disease severity of coronavirus disease 2019 (COVID-19). …

Background Respiratory failure is a key feature of severe Covid-19 and a critical driver of
mortality, but for reasons poorly defined affects less than 10% of SARS-CoV-2 infected patients. …

T cells are involved in the early identification and clearance of viral infections and also
support the development of antibodies by B cells. This central role for T cells makes them a …

T-cell acute lymphoblastic leukemia (T-ALL) accounts for approximately 15% and 25% of
childhood and adult cases of ALL, respectively, 1, 2 and is associated with a less favorable …

Understanding the cause of sex disparities in COVID-19 outcomes is a major challenge. We
investigate sex hormone levels and their association with outcomes in COVID-19 patients, …

Growing evidence suggests that conventional dendritic cells (cDCs) undergo aberrant
maturation in COVID‐19, which negatively affects T‐cell activation. The presence of effector T …